New Study Renders Anti-Trump Hydroxychloroquine Skeptics Totally Mute
(Tea Party 247) – The anti-malaria drug that was in wide use and considered perfectly safe in the United States until President Trump began to tout its possible benefits in treating the novel coronavirus just so happens to have successfully lowered the death rate among those hospitalized with COVID-19, according to a new study.
The study was conducted by Henry Ford Health System and published on Thursday in the peer-reviewed International Journal of Infectious Diseases.
It examined 2,541 patients who had been hospitalized in six hospitals between March 10 and May 2, 2020, Just the News reported.
Over twenty-six percent (26.4%) of patients who were not administered the drug perished.
Among those who were given hydroxychloroquine, however, only half, just 13% died.
Just the News explains:
More than 90% of the patients received hydroxychloroquine within 48 hours of admission to the hospital. Scientists say giving the drug early during illness may be a key to success.
The study’s authors also found one concern flagged in previous reports about hydroxychloroquine did not materialize: heart-related adverse events.
“The data here is clear that there was benefit to using [hydroxychloroquine] as a treatment for sick, hospitalized patients,” said Dr. Steven Kalkanis of Henry Ford Health System.
The study scientists point out that other reports about hydroxychloroquine as a treatment for coronavirus that had less positive, mixed, or negative results studied different populations; administered hydroxychloroquine later during illness; used different doses, and/or were not peer-reviewed.
The moment that President Trump began touting the possible benefits of the drug, the mainstream media, fully confirming their lack of interest in perpetuating any information other than anti-Trumpism, immediately began to cast doubt on the efficacy of the drug.
In May, Trump triggered reporters to tears when he revealed that he was in the middle of a course of the drug as a prophylactic measure after several members of the White House staff had tested positive for Covid-19.
Henry Ford Health Systems is also studying 3,000 frontline healthcare workers to determine if the drug is effective at preventing the coronavirus in a study titled “Will Hydroxychloroquine Impede or Prevent COVID-19” or “WHIP COVID-19.”
Just the News also notes:
However, the study scientists say negative publicity and safety concerns about hydroxychloroquine — some of which they say is inaccurate or out of context — has made it difficult to recruit enough volunteers to take part.
“Currently, the drug should be used only in hospitalized patients with appropriate monitoring, and as part of study protocols, in accordance with all relevant federal regulations,” says Dr. Marcus Zervos, co-author of study.
Dozens of drugs are currently under study as possible treatments for coronavirus and multiple potential vaccines are in development.
Cardiologist Dr. William O’Neill, a medical director at the Henry Ford Health System in Detroit, Michigan, first spoke with “Full Measure” about the study while it was underway in May.